Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Lammering

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 12, 2011
Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusionMarco H M Janssen, Hugo J W L Aerts, Jeroen Buijsen, et al.
Oncogene|May 31, 2002
Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cellsJoseph N Contessa, Jaime Hampton, Guido Lammering, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2007
Expression of EGFR variant vIII promotes both radiation resistance and hypoxia toleranceSherry A Weppler, Younan Li, Ludwig Dubois, et al.
Oncogene|August 29, 2003
EGFRvIII-mediated radioresistance through a strong cytoprotective responseGuido Lammering, Theodore H Hewit, Kristoffer Valerie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2011
E-Cadherin loss associated with EMT promotes radioresistance in human tumor cellsJan Theys, Barry Jutten, Roger Habets, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Tumor control probability predictions for genetic radiotherapyPaul J Keall, Guido Lammering, Peck-Sun Lin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 17, 2011
Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancerJørgen van den Bogaard, Marco H M Janssen, G Janssens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivityGuido Lammering, Theodore H Hewit, Mathew Holmes, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2011
Bevacizumab as a treatment option for radiation-induced cerebral necrosisChristiane Matuschek, Edwin Bölke, Jens Nawatny, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
Active breathing control in combination with ultrasound imaging: a feasibility study of image guidance in stereotactic body radiation therapy of liver lesionsEsther Bloemen-van Gurp, Skadi van der Meer, Janet Hendry, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|March 12, 2011
Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusionMarco H M Janssen, Hugo J W L Aerts, Jeroen Buijsen, et al.
Oncogene|May 31, 2002
Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cellsJoseph N Contessa, Jaime Hampton, Guido Lammering, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2007
Expression of EGFR variant vIII promotes both radiation resistance and hypoxia toleranceSherry A Weppler, Younan Li, Ludwig Dubois, et al.
Oncogene|August 29, 2003
EGFRvIII-mediated radioresistance through a strong cytoprotective responseGuido Lammering, Theodore H Hewit, Kristoffer Valerie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2011
E-Cadherin loss associated with EMT promotes radioresistance in human tumor cellsJan Theys, Barry Jutten, Roger Habets, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Tumor control probability predictions for genetic radiotherapyPaul J Keall, Guido Lammering, Peck-Sun Lin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 17, 2011
Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancerJørgen van den Bogaard, Marco H M Janssen, G Janssens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivityGuido Lammering, Theodore H Hewit, Mathew Holmes, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2011
Bevacizumab as a treatment option for radiation-induced cerebral necrosisChristiane Matuschek, Edwin Bölke, Jens Nawatny, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
Active breathing control in combination with ultrasound imaging: a feasibility study of image guidance in stereotactic body radiation therapy of liver lesionsEsther Bloemen-van Gurp, Skadi van der Meer, Janet Hendry, et al.
Pageof 8